Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium
Crossref DOI link: https://doi.org/10.1186/2049-6958-9-64
Published Online: 2014-12-08
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pelaia, Girolamo
Maselli, Rosario
Gallelli, Luca
Article History
Received: 21 October 2014
Accepted: 13 November 2014
First Online: 8 December 2014